Cost effectiveness of peginterferon α-2b plus ribavirin versus interferon α-2b plus ribavirin for initial treatment of chronic hepatitis C

Background: Peginterferon α-2b plus ribavirin therapy in previously untreated patients with chronic hepatitis C yields the highest sustained virological response rates of any treatment strategy but is expensive. Aims: To estimate the cost effectiveness of treatment with peginterferon α-2b plus ribav...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Siebert, U, Sroczynski, G, Rossol, S, Wasem, J, Ravens-Sieberer, U, Kurth, B M, Manns, M P, McHutchison, J G, Wong, J B
格式: Artigo
語言:Inglês
出版: Copyright 2003 by Gut 2003
主題:
Hepatitis
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC1773554/
https://ncbi.nlm.nih.gov/pubmed/12584228
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍